Skip to content

Prenatal Surgical Repair of Fetal Myelomeningocele

Prenatal Surgical Repair of Fetal Myelomeningocele

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01983345
Acronym
PRIUM
Enrollment
38
Registered
2013-11-14
Start date
2014-07-10
Completion date
2021-07-28
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foetus With Myelomeningocele

Keywords

Myelomeningocele, Arnold Chiari malformation, Spina bifida

Brief summary

The open surgical repair of myelomeningoceles before 26 weeks gestational age provides a correction of the anomaly of Chiarri, reduces the incidence of ventriculomegaly (defined as a measure of the ventricles at the crossroads ≥ 10 mm), and get a lower of injury than one corresponding to the anatomical defect (as defined by the last upper normal vertebra before the defect). The purpose of this study is to introduce in France an innovative technique for prenatal repair of myelomeningocele until now developed only on the American continent.

Detailed description

Spina bifida (SB) represents one of the most severe congenital malformation of the central nervous system and amenable to prenatal diagnosis. In the past 20 years, prenatal repair of SB has become an established technique. The PRIUM study will include 10 cases of fetuses with prenatal diagnosis of SB and for whom the maternal willing will be to continue the pregnancy. A surgical prenatal repair of the defect will be planed at 19-25+6 weeks gestation following maternal laparotomy and hysterotomy under maternal general anesthesia. The delivery will be planed at 36 weeks'. Postnatal evaluation of the neonates will be scheduled at birth, 1 month, 12 months and 36 months of age. Those data will be matched to controls who have underwent a conventional postnatal repair of the SB

Interventions

PROCEDUREprenatal surgical repair of fetal myelomeningocele

open surgical repair of myelomeningocele before 26 weeks gestational age

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient of majority age, with an assumption by health insurance, understanding and speaking French * A term between 19 and 25 +6 weeks gestational age (not for control) * Single-Pregnancy * Normal fetal karyotype * Myelomeningocele with higher-level defect between S1 and T1 * Placenta not low-inserted or not covering * Fault-isolated ultrasound reference

Exclusion criteria

* Age under 18 years * Patient foreigner who understands not French * Multiple Pregnancy * Low Placenta inserted or covering * Severe kyphosis * Placental abruption * Fetal malformation unrelated to the existence of myelomeningocele (the existence of a malposition of one or both feet do not represent an exclusion criterion) * Increased risk of preterm birth: a history of preterm delivery before 37 weeks gestational age, cervical length \<26 mm before 26 weeks gestational age (not for control) * Bleeding active between 20 and 26 weeks gestational age (not for control) * Maternal obesity with BMI\> 35 (not for control) * History of uterine surgery involving the anterior surface of the uterus (not for control) * Maternal contradiction in surgery or general anesthesia (not for control)

Design outcomes

Primary

MeasureTime frameDescription
Arnold Chiari anomaly at birthDay 0the existence of an Arnold Chiari anomaly at birth
Defect3 yearsthe level difference between the observed level of injury and the anatomical level of the defect (as defined by the last normal upper vertebra before the defect)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026